HealthsystemCIO.com January 31, 2023
Kate Gamble

It’s probably not surprising to learn that City of Hope, one of the top cancer and research centers in the United States, has invested a great deal in precision medicine. What’s a bit more interesting is that, unlike in past years, precision medicine — a care model that provided targeted treatments based on genetic or molecular profiling — is no longer limited to certain types of organizations. Now, integrated networks like Mass General Brigham and even community hospitals like Frederick Health have entered the fray, and are realizing the myriad benefits of precision medicine.

“We believe it’s here,” said Jackie Rice, CIO at Frederick Health. “We believe it’s going to make a difference in the community.”

Alistair Erskine, MD, Chief...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Health System / Hospital, Pharma / Biotech, Precision Medicine, Provider, Trends
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article